Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation.
Orlikova-Boyer B, Lorant A, Gajulapalli SR, Cerella C, Schnekenburger M, Lee JY, Paik JY, Lee Y, Siegel D, Ross D, Han BW, Nguyen TKY, Christov C, Kang HJ, Dicato M, Diederich M.
Orlikova-Boyer B, et al. Among authors: lee y.
Biomark Res. 2024 May 4;12(1):47. doi: 10.1186/s40364-024-00594-w.
Biomark Res. 2024.
PMID: 38704604